カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のノルエピネフリン重酒石酸塩注射市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Norepinephrine Bitartrate Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19464）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19464
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のノルエピネフリン重酒石酸塩注射市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ノルエピネフリン重酒石酸塩注射市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のノルエピネフリン重酒石酸塩注射の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ノルエピネフリン重酒石酸塩注射市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・2mg、4mg、その他

用途別セグメントは次のように区分されます。
・ショック降圧、AMI 低血圧、その他

世界のノルエピネフリン重酒石酸塩注射市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Novartis、Teva、Amneal Biosciences、Baxter、Mylan、Hikma Pharmaceuticals、Shanghai Harvest、Grand Pharmaceutical、King York

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ノルエピネフリン重酒石酸塩注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なノルエピネフリン重酒石酸塩注射メーカーの企業概要、2019年～2022年までのノルエピネフリン重酒石酸塩注射の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なノルエピネフリン重酒石酸塩注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ノルエピネフリン重酒石酸塩注射の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのノルエピネフリン重酒石酸塩注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのノルエピネフリン重酒石酸塩注射市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびノルエピネフリン重酒石酸塩注射の産業チェーンを掲載しています。
・第13、14、15章では、ノルエピネフリン重酒石酸塩注射の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ノルエピネフリン重酒石酸塩注射の概要
- 種類別分析（2017年vs2021年vs2028年）：2mg、4mg、その他
- 用途別分析（2017年vs2021年vs2028年）：ショック降圧、AMI 低血圧、その他
- 世界のノルエピネフリン重酒石酸塩注射市場規模・予測
- 世界のノルエピネフリン重酒石酸塩注射生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、Novartis、Teva、Amneal Biosciences、Baxter、Mylan、Hikma Pharmaceuticals、Shanghai Harvest、Grand Pharmaceutical、King York
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：2mg、4mg、その他
・用途別分析2017年-2028年：ショック降圧、AMI 低血圧、その他
・ノルエピネフリン重酒石酸塩注射の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ノルエピネフリン重酒石酸塩注射のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ノルエピネフリン重酒石酸塩注射のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ノルエピネフリン重酒石酸塩注射の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ノルエピネフリン重酒石酸塩注射の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Norepinephrine Bitartrate Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Norepinephrine Bitartrate Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Shock Hypotensive accounting for % of the Norepinephrine Bitartrate Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 2mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Norepinephrine Bitartrate Injection include Pfizer, Novartis, Teva, Amneal Biosciences, and Baxter, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Norepinephrine Bitartrate Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
2mg
4mg
Other
Market segment by Application can be divided into
Shock Hypotensive
AMI Hypotension
Other
The key market players for global Norepinephrine Bitartrate Injection market are listed below:
Pfizer
Novartis
Teva
Amneal Biosciences
Baxter
Mylan
Hikma Pharmaceuticals
Shanghai Harvest
Grand Pharmaceutical
King York
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Norepinephrine Bitartrate Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Norepinephrine Bitartrate Injection, with price, sales, revenue and global market share of Norepinephrine Bitartrate Injection from 2019 to 2022.
Chapter 3, the Norepinephrine Bitartrate Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Norepinephrine Bitartrate Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Norepinephrine Bitartrate Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Norepinephrine Bitartrate Injection.
Chapter 13, 14, and 15, to describe Norepinephrine Bitartrate Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Norepinephrine Bitartrate Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Norepinephrine Bitartrate Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 2mg
1.2.3 4mg
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Norepinephrine Bitartrate Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Shock Hypotensive
1.3.3 AMI Hypotension
1.3.4 Other
1.4 Global Norepinephrine Bitartrate Injection Market Size & Forecast
1.4.1 Global Norepinephrine Bitartrate Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Norepinephrine Bitartrate Injection Sales in Volume (2017-2028)
1.4.3 Global Norepinephrine Bitartrate Injection Price (2017-2028)
1.5 Global Norepinephrine Bitartrate Injection Production Capacity Analysis
1.5.1 Global Norepinephrine Bitartrate Injection Total Production Capacity (2017-2028)
1.5.2 Global Norepinephrine Bitartrate Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Norepinephrine Bitartrate Injection Market Drivers
1.6.2 Norepinephrine Bitartrate Injection Market Restraints
1.6.3 Norepinephrine Bitartrate Injection Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Norepinephrine Bitartrate Injection Product and Services
2.1.4 Pfizer Norepinephrine Bitartrate Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Norepinephrine Bitartrate Injection Product and Services
2.2.4 Novartis Norepinephrine Bitartrate Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Norepinephrine Bitartrate Injection Product and Services
2.3.4 Teva Norepinephrine Bitartrate Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Amneal Biosciences
2.4.1 Amneal Biosciences Details
2.4.2 Amneal Biosciences Major Business
2.4.3 Amneal Biosciences Norepinephrine Bitartrate Injection Product and Services
2.4.4 Amneal Biosciences Norepinephrine Bitartrate Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Baxter
2.5.1 Baxter Details
2.5.2 Baxter Major Business
2.5.3 Baxter Norepinephrine Bitartrate Injection Product and Services
2.5.4 Baxter Norepinephrine Bitartrate Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Norepinephrine Bitartrate Injection Product and Services
2.6.4 Mylan Norepinephrine Bitartrate Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hikma Pharmaceuticals
2.7.1 Hikma Pharmaceuticals Details
2.7.2 Hikma Pharmaceuticals Major Business
2.7.3 Hikma Pharmaceuticals Norepinephrine Bitartrate Injection Product and Services
2.7.4 Hikma Pharmaceuticals Norepinephrine Bitartrate Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Shanghai Harvest
2.8.1 Shanghai Harvest Details
2.8.2 Shanghai Harvest Major Business
2.8.3 Shanghai Harvest Norepinephrine Bitartrate Injection Product and Services
2.8.4 Shanghai Harvest Norepinephrine Bitartrate Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Grand Pharmaceutical
2.9.1 Grand Pharmaceutical Details
2.9.2 Grand Pharmaceutical Major Business
2.9.3 Grand Pharmaceutical Norepinephrine Bitartrate Injection Product and Services
2.9.4 Grand Pharmaceutical Norepinephrine Bitartrate Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 King York
2.10.1 King York Details
2.10.2 King York Major Business
2.10.3 King York Norepinephrine Bitartrate Injection Product and Services
2.10.4 King York Norepinephrine Bitartrate Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Norepinephrine Bitartrate Injection Breakdown Data by Manufacturer
3.1 Global Norepinephrine Bitartrate Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Norepinephrine Bitartrate Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Norepinephrine Bitartrate Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Norepinephrine Bitartrate Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Norepinephrine Bitartrate Injection Manufacturer Market Share in 2021
3.5 Global Norepinephrine Bitartrate Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Norepinephrine Bitartrate Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Norepinephrine Bitartrate Injection Market Size by Region
4.1.1 Global Norepinephrine Bitartrate Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Norepinephrine Bitartrate Injection Revenue by Region (2017-2028)
4.2 North America Norepinephrine Bitartrate Injection Revenue (2017-2028)
4.3 Europe Norepinephrine Bitartrate Injection Revenue (2017-2028)
4.4 Asia-Pacific Norepinephrine Bitartrate Injection Revenue (2017-2028)
4.5 South America Norepinephrine Bitartrate Injection Revenue (2017-2028)
4.6 Middle East and Africa Norepinephrine Bitartrate Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Norepinephrine Bitartrate Injection Sales in Volume by Type (2017-2028)
5.2 Global Norepinephrine Bitartrate Injection Revenue by Type (2017-2028)
5.3 Global Norepinephrine Bitartrate Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Norepinephrine Bitartrate Injection Sales in Volume by Application (2017-2028)
6.2 Global Norepinephrine Bitartrate Injection Revenue by Application (2017-2028)
6.3 Global Norepinephrine Bitartrate Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Norepinephrine Bitartrate Injection Sales by Type (2017-2028)
7.2 North America Norepinephrine Bitartrate Injection Sales by Application (2017-2028)
7.3 North America Norepinephrine Bitartrate Injection Market Size by Country
7.3.1 North America Norepinephrine Bitartrate Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Norepinephrine Bitartrate Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Norepinephrine Bitartrate Injection Sales by Type (2017-2028)
8.2 Europe Norepinephrine Bitartrate Injection Sales by Application (2017-2028)
8.3 Europe Norepinephrine Bitartrate Injection Market Size by Country
8.3.1 Europe Norepinephrine Bitartrate Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Norepinephrine Bitartrate Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Norepinephrine Bitartrate Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Norepinephrine Bitartrate Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Norepinephrine Bitartrate Injection Market Size by Region
9.3.1 Asia-Pacific Norepinephrine Bitartrate Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Norepinephrine Bitartrate Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Norepinephrine Bitartrate Injection Sales by Type (2017-2028)
10.2 South America Norepinephrine Bitartrate Injection Sales by Application (2017-2028)
10.3 South America Norepinephrine Bitartrate Injection Market Size by Country
10.3.1 South America Norepinephrine Bitartrate Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Norepinephrine Bitartrate Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Norepinephrine Bitartrate Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Norepinephrine Bitartrate Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Norepinephrine Bitartrate Injection Market Size by Country
11.3.1 Middle East & Africa Norepinephrine Bitartrate Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Norepinephrine Bitartrate Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Norepinephrine Bitartrate Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Norepinephrine Bitartrate Injection
12.3 Norepinephrine Bitartrate Injection Production Process
12.4 Norepinephrine Bitartrate Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Norepinephrine Bitartrate Injection Typical Distributors
13.3 Norepinephrine Bitartrate Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Norepinephrine Bitartrate Injection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Norepinephrine Bitartrate Injection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Norepinephrine Bitartrate Injection Product and Services
Table 6. Pfizer Norepinephrine Bitartrate Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Norepinephrine Bitartrate Injection Product and Services
Table 10. Novartis Norepinephrine Bitartrate Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Teva Basic Information, Manufacturing Base and Competitors
Table 12. Teva Major Business
Table 13. Teva Norepinephrine Bitartrate Injection Product and Services
Table 14. Teva Norepinephrine Bitartrate Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Amneal Biosciences Basic Information, Manufacturing Base and Competitors
Table 16. Amneal Biosciences Major Business
Table 17. Amneal Biosciences Norepinephrine Bitartrate Injection Product and Services
Table 18. Amneal Biosciences Norepinephrine Bitartrate Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Baxter Basic Information, Manufacturing Base and Competitors
Table 20. Baxter Major Business
Table 21. Baxter Norepinephrine Bitartrate Injection Product and Services
Table 22. Baxter Norepinephrine Bitartrate Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Norepinephrine Bitartrate Injection Product and Services
Table 26. Mylan Norepinephrine Bitartrate Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Hikma Pharmaceuticals Major Business
Table 29. Hikma Pharmaceuticals Norepinephrine Bitartrate Injection Product and Services
Table 30. Hikma Pharmaceuticals Norepinephrine Bitartrate Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Shanghai Harvest Basic Information, Manufacturing Base and Competitors
Table 32. Shanghai Harvest Major Business
Table 33. Shanghai Harvest Norepinephrine Bitartrate Injection Product and Services
Table 34. Shanghai Harvest Norepinephrine Bitartrate Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Grand Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Grand Pharmaceutical Major Business
Table 37. Grand Pharmaceutical Norepinephrine Bitartrate Injection Product and Services
Table 38. Grand Pharmaceutical Norepinephrine Bitartrate Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. King York Basic Information, Manufacturing Base and Competitors
Table 40. King York Major Business
Table 41. King York Norepinephrine Bitartrate Injection Product and Services
Table 42. King York Norepinephrine Bitartrate Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Norepinephrine Bitartrate Injection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Norepinephrine Bitartrate Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Norepinephrine Bitartrate Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Norepinephrine Bitartrate Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Norepinephrine Bitartrate Injection Production Site of Key Manufacturer
Table 48. Norepinephrine Bitartrate Injection New Entrant and Capacity Expansion Plans
Table 49. Norepinephrine Bitartrate Injection Mergers & Acquisitions in the Past Five Years
Table 50. Global Norepinephrine Bitartrate Injection Sales by Region (2017-2022) & (K Units)
Table 51. Global Norepinephrine Bitartrate Injection Sales by Region (2023-2028) & (K Units)
Table 52. Global Norepinephrine Bitartrate Injection Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Norepinephrine Bitartrate Injection Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Norepinephrine Bitartrate Injection Sales by Type (2017-2022) & (K Units)
Table 55. Global Norepinephrine Bitartrate Injection Sales by Type (2023-2028) & (K Units)
Table 56. Global Norepinephrine Bitartrate Injection Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Norepinephrine Bitartrate Injection Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Norepinephrine Bitartrate Injection Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Norepinephrine Bitartrate Injection Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Norepinephrine Bitartrate Injection Sales by Application (2017-2022) & (K Units)
Table 61. Global Norepinephrine Bitartrate Injection Sales by Application (2023-2028) & (K Units)
Table 62. Global Norepinephrine Bitartrate Injection Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Norepinephrine Bitartrate Injection Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Norepinephrine Bitartrate Injection Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Norepinephrine Bitartrate Injection Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Norepinephrine Bitartrate Injection Sales by Country (2017-2022) & (K Units)
Table 67. North America Norepinephrine Bitartrate Injection Sales by Country (2023-2028) & (K Units)
Table 68. North America Norepinephrine Bitartrate Injection Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Norepinephrine Bitartrate Injection Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Norepinephrine Bitartrate Injection Sales by Type (2017-2022) & (K Units)
Table 71. North America Norepinephrine Bitartrate Injection Sales by Type (2023-2028) & (K Units)
Table 72. North America Norepinephrine Bitartrate Injection Sales by Application (2017-2022) & (K Units)
Table 73. North America Norepinephrine Bitartrate Injection Sales by Application (2023-2028) & (K Units)
Table 74. Europe Norepinephrine Bitartrate Injection Sales by Country (2017-2022) & (K Units)
Table 75. Europe Norepinephrine Bitartrate Injection Sales by Country (2023-2028) & (K Units)
Table 76. Europe Norepinephrine Bitartrate Injection Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Norepinephrine Bitartrate Injection Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Norepinephrine Bitartrate Injection Sales by Type (2017-2022) & (K Units)
Table 79. Europe Norepinephrine Bitartrate Injection Sales by Type (2023-2028) & (K Units)
Table 80. Europe Norepinephrine Bitartrate Injection Sales by Application (2017-2022) & (K Units)
Table 81. Europe Norepinephrine Bitartrate Injection Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Norepinephrine Bitartrate Injection Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Norepinephrine Bitartrate Injection Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Norepinephrine Bitartrate Injection Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Norepinephrine Bitartrate Injection Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Norepinephrine Bitartrate Injection Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Norepinephrine Bitartrate Injection Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Norepinephrine Bitartrate Injection Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Norepinephrine Bitartrate Injection Sales by Application (2023-2028) & (K Units)
Table 90. South America Norepinephrine Bitartrate Injection Sales by Country (2017-2022) & (K Units)
Table 91. South America Norepinephrine Bitartrate Injection Sales by Country (2023-2028) & (K Units)
Table 92. South America Norepinephrine Bitartrate Injection Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Norepinephrine Bitartrate Injection Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Norepinephrine Bitartrate Injection Sales by Type (2017-2022) & (K Units)
Table 95. South America Norepinephrine Bitartrate Injection Sales by Type (2023-2028) & (K Units)
Table 96. South America Norepinephrine Bitartrate Injection Sales by Application (2017-2022) & (K Units)
Table 97. South America Norepinephrine Bitartrate Injection Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Norepinephrine Bitartrate Injection Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Norepinephrine Bitartrate Injection Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Norepinephrine Bitartrate Injection Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Norepinephrine Bitartrate Injection Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Norepinephrine Bitartrate Injection Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Norepinephrine Bitartrate Injection Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Norepinephrine Bitartrate Injection Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Norepinephrine Bitartrate Injection Sales by Application (2023-2028) & (K Units)
Table 106. Norepinephrine Bitartrate Injection Raw Material
Table 107. Key Manufacturers of Norepinephrine Bitartrate Injection Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Norepinephrine Bitartrate Injection Typical Distributors
Table 111. Norepinephrine Bitartrate Injection Typical Customers
List of Figures
Figure 1. Norepinephrine Bitartrate Injection Picture
Figure 2. Global Norepinephrine Bitartrate Injection Revenue Market Share by Type in 2021
Figure 3. 2mg
Figure 4. 4mg
Figure 5. Other
Figure 6. Global Norepinephrine Bitartrate Injection Revenue Market Share by Application in 2021
Figure 7. Shock Hypotensive
Figure 8. AMI Hypotension
Figure 9. Other
Figure 10. Global Norepinephrine Bitartrate Injection Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Norepinephrine Bitartrate Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Norepinephrine Bitartrate Injection Sales (2017-2028) & (K Units)
Figure 13. Global Norepinephrine Bitartrate Injection Price (2017-2028) & (US$/Unit)
Figure 14. Global Norepinephrine Bitartrate Injection Production Capacity (2017-2028) & (K Units)
Figure 15. Global Norepinephrine Bitartrate Injection Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Norepinephrine Bitartrate Injection Market Drivers
Figure 17. Norepinephrine Bitartrate Injection Market Restraints
Figure 18. Norepinephrine Bitartrate Injection Market Trends
Figure 19. Global Norepinephrine Bitartrate Injection Sales Market Share by Manufacturer in 2021
Figure 20. Global Norepinephrine Bitartrate Injection Revenue Market Share by Manufacturer in 2021
Figure 21. Norepinephrine Bitartrate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Norepinephrine Bitartrate Injection Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Norepinephrine Bitartrate Injection Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Norepinephrine Bitartrate Injection Sales Market Share by Region (2017-2028)
Figure 25. Global Norepinephrine Bitartrate Injection Revenue Market Share by Region (2017-2028)
Figure 26. North America Norepinephrine Bitartrate Injection Revenue (2017-2028) & (USD Million)
Figure 27. Europe Norepinephrine Bitartrate Injection Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Norepinephrine Bitartrate Injection Revenue (2017-2028) & (USD Million)
Figure 29. South America Norepinephrine Bitartrate Injection Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Norepinephrine Bitartrate Injection Revenue (2017-2028) & (USD Million)
Figure 31. Global Norepinephrine Bitartrate Injection Sales Market Share by Type (2017-2028)
Figure 32. Global Norepinephrine Bitartrate Injection Revenue Market Share by Type (2017-2028)
Figure 33. Global Norepinephrine Bitartrate Injection Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Norepinephrine Bitartrate Injection Sales Market Share by Application (2017-2028)
Figure 35. Global Norepinephrine Bitartrate Injection Revenue Market Share by Application (2017-2028)
Figure 36. Global Norepinephrine Bitartrate Injection Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Norepinephrine Bitartrate Injection Sales Market Share by Type (2017-2028)
Figure 38. North America Norepinephrine Bitartrate Injection Sales Market Share by Application (2017-2028)
Figure 39. North America Norepinephrine Bitartrate Injection Sales Market Share by Country (2017-2028)
Figure 40. North America Norepinephrine Bitartrate Injection Revenue Market Share by Country (2017-2028)
Figure 41. United States Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Norepinephrine Bitartrate Injection Sales Market Share by Type (2017-2028)
Figure 45. Europe Norepinephrine Bitartrate Injection Sales Market Share by Application (2017-2028)
Figure 46. Europe Norepinephrine Bitartrate Injection Sales Market Share by Country (2017-2028)
Figure 47. Europe Norepinephrine Bitartrate Injection Revenue Market Share by Country (2017-2028)
Figure 48. Germany Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Norepinephrine Bitartrate Injection Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Norepinephrine Bitartrate Injection Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Norepinephrine Bitartrate Injection Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Norepinephrine Bitartrate Injection Revenue Market Share by Region (2017-2028)
Figure 57. China Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Norepinephrine Bitartrate Injection Sales Market Share by Type (2017-2028)
Figure 64. South America Norepinephrine Bitartrate Injection Sales Market Share by Application (2017-2028)
Figure 65. South America Norepinephrine Bitartrate Injection Sales Market Share by Country (2017-2028)
Figure 66. South America Norepinephrine Bitartrate Injection Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Norepinephrine Bitartrate Injection Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Norepinephrine Bitartrate Injection Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Norepinephrine Bitartrate Injection Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Norepinephrine Bitartrate Injection Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Norepinephrine Bitartrate Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Norepinephrine Bitartrate Injection in 2021
Figure 78. Manufacturing Process Analysis of Norepinephrine Bitartrate Injection
Figure 79. Norepinephrine Bitartrate Injection Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のノルエピネフリン薬市場2022年：市場規模予測（～2028年）
  • 世界のリラグルチド注射市場2022年：市場規模予測（～2028年）
  • 世界のエダラボン注射市場2022年：市場規模予測（～2028年）
  • 世界のバシリキシマブ注射市場2022年：市場規模予測（～2028年）
  • 世界のクリスビタ注射市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19464 )"世界のノルエピネフリン重酒石酸塩注射市場2022年：市場規模予測（～2028年）" (英文：Global Norepinephrine Bitartrate Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。